![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
CSPC Pharmaceutical Group Limited | TG:CVG | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0106 | -1.48% | 0.7076 | 0.6932 | 0.7228 | 0.6946 | 0.6946 | 0.6946 | 215 | 22:50:08 |
RNS Number:3830K Intelliplus Group PLC 25 April 2003 Release: 25th April 2003 Intelliplus Group plc ("the Company") Notification of Shareholding The Company was notified on 23rd April 2003 that on the 10th April 2003, Convergent Communications Plc sold 44,123,200 ordinary shares of 1 pence each in the Company. Convergent Communications Plc no longer has a notifiable interest in the Company. Mike Neville, Executive Chairman Tel: 0870 880 2020 Intelliplus Group plc Adam Reynolds/Brigitte Atkinson Tel: 020 7245 1100 Hansard Communications Adam@hansardcommunications.com www.hansardcommunications.com This information is provided by RNS The company news service from the London Stock Exchange END HOLPUUWACUPWGUA
1 Year CSPC Pharmaceutical Chart |
1 Month CSPC Pharmaceutical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions